Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Enovis (ENOV)
NYSE:ENOV
Holding ENOV?
Track your performance easily
ENOV Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$39.98 - $65.03
Previous Close$43.64
Volume635.82K
Average Volume (3M)632.09K
Market Cap
$2.44B
Enterprise Value$3.75B
Total Cash (Recent Filing)$35.00M
Total Debt (Recent Filing)$1.34B
Price to Earnings (P/E)―
Beta1.15
Next Earnings
Oct 31, 2024EPS Estimate
$0.62Last Dividend Ex-Date
Apr 05, 2022Dividend YieldN/A
Share Statistics
EPS (TTM)-1.94
Shares Outstanding55,850,500
10 Day Avg. Volume637,245
30 Day Avg. Volume632,090
Standard Deviation0.17
R-Squared0.50
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)0.77
Price to Sales (P/S)1.27
Price to Cash Flow (P/CF)78.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.96
Enterprise Value/Gross Profit3.78
Enterprise Value/Ebitda21.58
Forecast
1Y Price Target
$65.17Price Target Upside44.76% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
Enovis News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceManagement narrowed its 2024 revenue guidance, maintained its EBITDA guidance, and raised its EPS guidance.
Market LeadershipEnovis is a leader in the $4B+ prevention & recovery markets and has a growing position in the $41B global orthopedic implant market.
Product And Market ExpansionThe combined portfolio, as well as product refreshes in its PnR business and new and recent launches targeting its high-growth recon segments, will help drive momentum.
Bears Say
Competitive ConcernsThis slower 2Q growth won't help address growing competitive concerns from investors regarding ENOV's U.S. shoulder business, and to a lesser extent U.S. hips/knees.
GrowthLack of upside vs. what looked like conservative 2Q guidance and slowing U.S. pro-forma growth is keeping a lid on investor sentiment.
Sales PerformanceSales were flat in the Americas, driven by growth in Canada, offset by soft performance in the U.S., partly due to a continued impact related to the Change Healthcare cyberattack.
---
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
ENOV FAQ
What was Enovis’s price range in the past 12 months?
Enovis lowest stock price was $39.98 and its highest was $65.03 in the past 12 months.
What is Enovis’s market cap?
Currently, no data Available
When is Enovis’s upcoming earnings report date?
Enovis’s upcoming earnings report date is Oct 31, 2024 which is in 41 days.
How were Enovis’s earnings last quarter?
Enovis released its earnings results on Aug 07, 2024. The company reported $0.62 earnings per share for the quarter, beating the consensus estimate of $0.593 by $0.027.
Is Enovis overvalued?
According to Wall Street analysts Enovis’s price is currently Undervalued.
Does Enovis pay dividends?
Enovis pays a Notavailable dividend of $16.67 which represents an annual dividend yield of N/A. See more information on Enovis dividends here
What is Enovis’s EPS estimate?
Enovis’s EPS estimate is $0.62.
How many shares outstanding does Enovis have?
Enovis has 55,850,500 shares outstanding.
What happened to Enovis’s price movement after its last earnings report?
Enovis reported an EPS of $0.62 in its last earnings report, beating expectations of $0.593. Following the earnings report the stock price went down -3.359%.
Which hedge fund is a major shareholder of Enovis?
Among the largest hedge funds holding Enovis’s share is Diamond Hill Capital Management Inc. It holds Enovis’s shares valued at 126M.
---
Enovis Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$65.17 (44.76% Upside)
$65.17 (44.76% Upside)
Blogger Sentiment
Bullish
ENOV Sentiment 100%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Increased
By 1.3M Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-18.44%
12-Months-Change
Fundamentals
Return on Equity
-3.18%
Trailing 12-Months
Asset Growth
22.47%
Trailing 12-Months
Company Description
Enovis
Colfax Corp. operates as a diversified technology company that provides orthopedic care and fabrication technology products and services to customers. The firm operates its business through the following segments: Medical Technology; and Fabrication Technology. The Medical Technology segment develops, manufactures and distributes medical devices with a broad range of products used for rehabilitation, pain management and physical therapy. The Fabrication Technology develops, manufactures, and supplies consumable products and equipment. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Annapolis Junction, MD.
---
ENOV Company Deck
---
ENOV Earnings Call
Q2 2024
0:00 / 0:00
---
ENOV Stock 12 Month Forecast
Average Price Target
$65.17
▲(44.76% Upside)
Technical Analysis
Best Analysts Covering ENOV
1 Year
---